Use of Opioid Agonist Therapy for Medicare Patients in 2013

JAMA Psychiatry - United States
doi 10.1001/jamapsychiatry.2016.1390
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Medicare Formulary Coverage and Restrictions for Opioid Potentiators From 2013 to 2017

Journal of General Internal Medicine
Internal Medicine
2019English

Personal Viewpoint on Opioid Agonist Therapy and Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Performance of the Centers for Medicare & Medicaid Services’ Opioid Overutilization Criteria for Classifying Opioid Use Disorder or Overdose

JAMA - Journal of the American Medical Association
Medicine
2019English

Declining Use Rates of Revascularization for Medicare Patients

Circulation
Cardiovascular MedicinePhysiologyCardiology
2015English

Better Agonist for the Opioid Receptors

Chemistry Central Journal
Chemistry
2018English

The Time for Emergency Department Opioid Agonist Therapy Is Now: “A BC Perspective”

Canadian Journal of Emergency Medicine
Emergency Medicine
2019English

Opioid and Polydrug Use Among Patients in Opioid Maintenance Treatment

Substance Abuse and Rehabilitation
2020English

Alcohol Screening Among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program

Journal of Psychoactive Drugs
MedicinePsychology
2015English

Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries

JAMA network open
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy